Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

15articles mentioning drugs

83drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Atogepant ×

Atogepant

This drug is selected. Its supporting articles are shown below.

Atogepant15

Articles mentioning Atogepant

15 articles · page 2 of 2

4CPS-304 Persistence analysis with anti-calcitonin gene-related peptide prophylactic treatments in patients with migraine

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

99.1%

galcanezumab fremanezumab erenumab eptinezumab rimegepant atogepant

…9% male; 64.6% received fremanezumab, 24.8% erenumab, 10.6% and galcanezumab; 75.7% were on first-line therapy, 21.7% second-line and 2.7% t…

4CPS-030 Real-world longitudinal outcomes of preventive treatments targeting the CGRP pathway in migraine: hit-6 and midas responder analysis according to the minimal clinically important difference (MCID)

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

97.4%

galcanezumab erenumab eptinezumab atogepant fremanezumab migraine preventive therapies

…he following CGRP pathway-targeted preventive treatments: 32.4% galcanezumab, 28.1% erenumab, 24.3% fremanezumab, 8.2% atogepant, 2.5% eptin…

4CPS-039 Effectiveness of gepants in naive patients versus patients previously treated with anti- CGRP monoclonal antibodies

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

92.5%

Gepants gepant rimegepant atogepant CM chronic migraine high-frequency episodic migraine HFEM anti-CGRP monoclonal antibodies

… constipation, nausea, and weight loss.Conclusion and Relevance Gepants used in the treatment of migraine appear to reduce migraine day…